

CNBC Special Report: How Soaring U.S. Drug Prices Fueled What Feds Call An Illegal Import Of Medications 11/27/25
Around the country, a pervasive question being asked: How can I afford my prescription drugs? The high cost of those medications, particularly very expensive drugs to treat serious diseases like multiple sclerosis and cystic fibrosis, have fueled a nationwide business in which insurance programs are using companies…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →
All the Headlines From the Nvidia Earnings Call

Countdown to NVIDIA Earnings, Anthropic IPO Watch, and More Tech Issues at Airlines

FAA Ground Stop, Anthropic IPO and What to Expect From Nvidia and Nike Next Week
Similar episodes from other shows
More like CNBC's "Fast Money" →
CNBC Special Report: Taking Stock 11/23/22

The Quest to Save American-Made Antibiotics

02.08.24 Rx Savings: The Quest Continues / To Employers: Enlightened Self-Interest

Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.